The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...
The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery ...
Nine states have been identified as being affected by the chocolate recall, but the products were available online so others ...
A major chocolate recall has been upgraded to the highest possible risk level.
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.